Shopping Cart
- Remove All
- Your shopping cart is currently empty
Razuprotafib (AKB-9778) is a protein tyrosine phosphatase ß (HPTPß) inhibitor with an IC50 of 50 nM. It effectively activates Tie-2 and provides protection against acute kidney injury.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $253 | In Stock | |
5 mg | $413 | In Stock | |
10 mg | $619 | In Stock | |
25 mg | $1,050 | In Stock | |
50 mg | $1,370 | In Stock | |
100 mg | $1,790 | In Stock | |
1 mL x 10 mM (in DMSO) | $533 | In Stock |
Description | Razuprotafib (AKB-9778) is a protein tyrosine phosphatase ß (HPTPß) inhibitor with an IC50 of 50 nM. It effectively activates Tie-2 and provides protection against acute kidney injury. |
Targets&IC50 | HPTPß:50 nM |
In vitro | Razuprotafib inhibits the phosphatase activity of VE-PTP with an IC50 of 17 pM.
Razuprotafib inhibits the phosphatase PTP1B with an IC50 of 780 nM. Razuprotafib inhibits HPTPη (IC50 = 36 pM) . Razuprotafib inhibits HPTPγ (IC50 = 100 pM). Razuprotafib 0.17 to 50 μM HUVEC 10 minutes in WB concentration-dependent phosphorylation of TIE2 and downstream components of the TIE2 signaling pathway, including eNOS, AKT, and ERK. |
In vivo | Rho-VEGF–transgenic mice s.c. injection 20 mg/kg 12 hours promotes phosphorylation of TIE2 in retinal endothelial cells
Rho-VEGF mice s.c. injection 10-20 mg/kg twice daily for 7 days suppresses subretinal neovascularization. |
Alias | AKB-9778 |
Molecular Weight | 586.7 |
Formula | C26H26N4O6S3 |
Cas No. | 1008510-37-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (170.44 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.